Sources
Greg Brockman
Our custom LLM, gpt-4b micro, has helped achieve an advance in biology. It designed novel variants of the Nobel-winning Yamanaka factors that achieve a 50x increase in reprogramming efficiency in vitro compared to standard OSKM proteins. https://t.co/lI3XP1hm8b
Andrew Curran OpenAI's protein engineering project with Retro Biosciences started two and a half years ago. They have been using GPT-4b since January, with the aim of extending the normal human lifespan by 10 years. Sam Altman was an early backer of Retro and invested $180 million in 2022. https://t.co/eXStOWSiIl
- Greg Brockman
GPT-4b micro – a new experimental biology model developed to see how LLMs can help push the frontiers of science. Applied to design novel variants of the Yamanaka factors that achieve a 50x increase in reprogramming efficiency in vitro compared to standard OSKM proteins. https://t.co/lI3XP1hm8b
